Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Long-circulating liposome freeze-drying oral preparation of magnolia cortex total phenol and preparation method of freeze-drying oral preparation

A long-circulation liposome and oral preparation technology, which is applied in liposome delivery, freeze-drying delivery, anti-inflammatory agents, etc., can solve the problems of no new dosage form of magnolol total phenols and limit the clinical application of magnolia , to achieve the effects of prolonging the residence time, reducing the number of medications and high blood drug concentration

Inactive Publication Date: 2018-05-08
HUBEI UNIV
View PDF5 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] At present, there are research reports on new dosage forms such as honokiol and magnolol monomer micelles, β-cyclodextrin nanoparticles, and liposomes, but there is no research on new dosage forms of magnolol, which limits The Clinical Application of Magnolia officinalis

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Long-circulating liposome freeze-drying oral preparation of magnolia cortex total phenol and preparation method of freeze-drying oral preparation
  • Long-circulating liposome freeze-drying oral preparation of magnolia cortex total phenol and preparation method of freeze-drying oral preparation
  • Long-circulating liposome freeze-drying oral preparation of magnolia cortex total phenol and preparation method of freeze-drying oral preparation

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0032] Magnolol long-circulating liposome lyophilized oral preparation, the composition of which is as follows:

[0033]

[0034] Preparation method: Weigh 6 mg of magnolol total phenols, 48 ​​mg of soybean lecithin, 6 mg of cholesterol, and 6 mg of DPPE-MPEG2000, add them to 220 ml of methanol-chloroform mixed organic solvent (4:1, v / v), place in an eggplant-shaped bottle, Stir at room temperature until completely dissolved to obtain a mixed solution with a total concentration of 0.3 mg / ml. The mixed solution was rotary evaporated under reduced pressure at 40° C. to remove the organic solvent until a thin film was formed on the inner wall of the bottle, and the vacuum was continued for 1 h to remove the residual organic solvent. Add 20ml of ultrapure water to the dried eggplant-shaped bottle to fully submerge the film on the wall of the bottle, stir and hydrate at 60°C for 1 hour, and then ultrasonicate at intervals in an ice bath (power 80W, ultrasonic at intervals of 4 s...

Embodiment 2

[0036] Magnolol long-circulating liposome lyophilized oral preparation, the composition of which is as follows:

[0037]

[0038] Preparation:

[0039] (1) Total magnolol, soybean lecithin, cholesterol, DPPE-MPEG2000 are added in methanol-chloroform mixed organic solvent (6:1, v / v), make total magnolol, soybean lecithin, cholesterol, DPPE-MPEG2000 The total concentration is 0.5mg / ml, stirred at room temperature until completely dissolved;

[0040] (2) Rotate the mixed solution under reduced pressure at 45°C to remove the organic solvent and form a thin film;

[0041] (3) Add water to the film, stir at 50°C, then sonicate in an ice bath, and finally pass through a microporous membrane (0.22 μm) to obtain a liposome suspension;

[0042] (4) Adding a lyoprotectant (trehalose: mannitol = 5:1) to the liposome suspension, freeze-dried to obtain.

Embodiment 3

[0044] Magnolol long-circulating liposome lyophilized oral preparation, the composition of which is as follows:

[0045]

[0046] Preparation:

[0047] (1) Total magnolol, soybean lecithin, cholesterol, DPPE-MPEG2000 are added in methanol-chloroform mixed organic solvent (10:1, v / v), make total magnolol, soybean lecithin, cholesterol, DPPE-MPEG2000 The total concentration is 0.7mg / ml, stirred at room temperature until completely dissolved;

[0048] (2) Rotate the mixed solution under reduced pressure at 50°C to remove the organic solvent and form a thin film;

[0049] (3) Add water to the film, stir at 70°C, then sonicate in an ice bath, and finally pass through a microporous membrane (0.22 μm) to obtain a liposome suspension;

[0050] (4) Adding a lyoprotectant (trehalose: mannitol = 9:1) to the liposome suspension and freeze-drying.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Apertureaaaaaaaaaa
Login to View More

Abstract

The invention discloses a long-circulating liposome freeze-drying oral preparation of magnolia cortex total phenol, which comprises the following ingredients by weight percentage: 2-10% of magnolia cortex total phenol, 40-70% of soybean lecithin, 2-10% of cholesterol, 2-10% of DPPE-MPEG (dipalmitoylphosphatidylethanolamine-methoxy polyethylene glycol) 2000 and 15-30% of freeze-drying protective agent. The liposome freeze-drying preparation of the magnolia cortex total phenol has a slow release effect in vitro; a medicine can be slowly released within 24h, so that the in-vivo retention time ofthe medicine is prolonged; and the medication frequency is reduced. A pharmacokinetic experiment result shows that the liposome freeze-drying preparation of the magnolia cortex total phenol has a higher blood concentration and a longer half life after intragastric administration; the medicine is absorbed quickly and eliminated slowly, is high in bioavailability and can serve as a long circulatingoral preparation; a new magnolia cortex total phenol dosage form that is safer and more effective and has a lasting effect is provided clinically.

Description

technical field [0001] The invention belongs to the field of pharmaceutical preparations, and relates to an oral preparation of total magnolol, especially a freeze-dried oral preparation of total magnolol long-circulation liposome, and also relates to a preparation method of the preparation. Background technique [0002] Magnolia officinalis is an important traditional Chinese medicinal material in my country, among which honokiol and magnolol are the main components, which have anti-oxidation, antibacterial, anti-virus, anti-tumor, anti-inflammatory and analgesic, anti-tumor, myocardial protection, Blood protection, calmodulin antagonism, liver protection, liver protection, anti-anxiety, anti-depression, anti-senile dementia, anti-morphine withdrawal reaction, inhibition of catecholamines, anti-coagulation, anti-ulcer and other pharmacological effects in Parkinson's disease. Honokiol and magnolol have poor water solubility and are easily oxidatively degraded. Their oral bioa...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K9/127A61K36/575A61K47/26A61K47/10A61K9/19A61P39/06A61P31/04A61P31/12A61P35/00A61P29/00A61P9/00A61P9/10A61P3/14A61P1/16A61P25/22A61P25/24A61P25/28A61P25/36A61P25/16A61P7/02A61P1/04A61P17/02
CPCA61K9/127A61K9/19A61K36/575A61K47/10A61K47/26
Inventor 陈勇刘红陈一桢张文娟王俏朱明丽秦吟刘文锦
Owner HUBEI UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com